Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands

Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands

US Patent 6608082 · Granted Aug 19, 2003

Estimated economic value: $162,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators2022
PLK4 inhibitors2020
Compositions and methods for enhancing proteasome activity2019
Tricyclic proteasome activity enhancing compounds2018
Tricyclic proteasome activity enhancing compounds2015
Inducible nitric oxide synthase dimerization inhibitors2010
Peptide nucleic acid conjugates2007
Peptide nucleic acid conjugates2007
FXR NR1H4 nuclear receptor binding compounds2006
NR1H4 nuclear receptor binding compounds2006
NR1H4 nuclear receptor binding compounds2005
Method of inhibiting amyloid protein aggregation and imaging amyloid deposits2005